21^st February 2025, Strasbourg

Mediso Medical Imaging Systems Ltd. today announced the establishment of Mediso France SAS, aimed at strengthening its presence in the French market.

Previously, Mediso has been represented in France by RS2D in a successful partnership, supplying and servicing preclinical research equipment, as well as developing the cryogen-free superconducting MRI-based nanoScan products. As of December 31, 2024, Mediso and RS2D have agreed to transfer all activities related to Mediso products to the newly established Mediso France subsidiary.

István Bagaméry, Managing Director of Mediso, commented: “France has always been considered one of the most important markets for Mediso, with preclinical installations spanning more than 15 years. The establishment of Mediso France strengthens our local presence, allows us to build closer relationships with our customers, and paves the way for establishing new strategic alliances."

Moving forward, Mediso France will have exclusive responsibility for sales and customer support for Mediso products and will operate with the same experienced and dedicated team.

Valentin Schimpf, Managing Director of Mediso France, said: "We have successfully developed and maintained a significant installed base over the past decade. By transitioning to a direct subsidiary, our experienced team will work in even closer collaboration with the manufacturer, allowing us to provide faster and more effective support."